277 results
Page 4 of 14
8-K
EX-99.2
mfz 30z67g
25 Jul 13
Bristol-Myers Squibb Reports Second Quarter 2013 Financial Results
12:00am
8-K
EX-99.2
2sefzh1s
25 Apr 13
Bristol-Myers Squibb Reports First Quarter 2013 Financial Results
12:00am
8-K
EX-99.2
7799n6h
24 Jan 13
Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2012 Financial Results
12:00am
8-K
EX-99.2
o6p0hj 4ece3p
24 Oct 12
Bristol-Myers Squibb Reports Third Quarter 2012 Financial Results
12:00am
8-K
EX-99.1
xxrcuz4 i23
24 Oct 12
Bristol-Myers Squibb Reports Third Quarter 2012 Financial Results
12:00am
8-K
EX-99.1
k5npd6y
25 Jul 12
Planned Acquisition of Amylin Expected to Add Two Marketed GLP-1 Agonists to Our Diabetes Franchise and Our Alliance with AstraZeneca
12:00am
8-K
EX-99.2
axboflwc7xzvvdn t8vi
25 Jul 12
Planned Acquisition of Amylin Expected to Add Two Marketed GLP-1 Agonists to Our Diabetes Franchise and Our Alliance with AstraZeneca
12:00am
8-K
EX-2.1
k72fb epvmjaeoqn
3 Jul 12
Entry into a Material Definitive Agreement
12:00am
CORRESP
f1ni twf1
17 May 12
Correspondence with SEC
12:00am
8-K
EX-99.2
yf668 7x56leehxs
26 Apr 12
Bristol-Myers Squibb Delivers a Solid First Quarter with Strong Operating Results and Key R&D Milestones
12:00am
8-K
EX-99.1
krt 8xeya
26 Apr 12
Bristol-Myers Squibb Delivers a Solid First Quarter with Strong Operating Results and Key R&D Milestones
12:00am